{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:59:05Z","timestamp":1778281145608,"version":"3.51.4"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,27]]},"abstract":"<jats:p>Atopic keratoconjunctivitis (AKC) is a potentially sight-threatening form of ocular surface inflammation, affecting up to 30% of patients with atopic dermatitis. This study highlights for the first time the potential value of Janus kinase inhibitors in the treatment of AKC and not only in managing dupilumab-induced ocular adverse events.<\/jats:p>","DOI":"10.1093\/bjd\/ljaf424","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T12:41:09Z","timestamp":1761482469000},"page":"390-392","source":"Crossref","is-referenced-by-count":1,"title":["Janus kinase inhibitors are effective in atopic keratoconjunctivitis treatment and not only in managing dupilumab-induced ocular adverse events"],"prefix":"10.1093","volume":"194","author":[{"given":"Yasmine","family":"Bendoukha","sequence":"first","affiliation":[{"name":"Department of Allergology, Erik Satie Centre, Rouen University Hospital , Rouen ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Jacob","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Rouen University Hospital , Rouen ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Muraine","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Rouen University Hospital , Rouen ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Te\u0301tart","sequence":"additional","affiliation":[{"name":"Department of Allergology, Erik Satie Centre, Rouen University Hospital , Rouen ,","place":["France"]},{"name":"Department of Dermatology, Rouen University Hospital , Rouen ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8592-3810","authenticated-orcid":false,"given":"Julie","family":"Gueudry","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Rouen University Hospital , Rouen ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"2026012706470916400_ljaf424-B1","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.3390\/jcm13133818","article-title":"Impact of upadacitinib on atopic keratoconjunctivitis exacerbated by dupilumab treatment in atopic dermatitis patients: a prospective dermatological and ophthalmological clinical evaluation in common clinical practice","volume":"13","author":"Paganini","year":"2024","journal-title":"J Clin Med"},{"key":"2026012706470916400_ljaf424-B2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaad.2020.08.051","article-title":"Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis","volume":"84","author":"Halling","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2026012706470916400_ljaf424-B3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaip.2024.12.001","article-title":"Switching from dupilumab to tralokinumab or Janus kinase inhibitors in cases of ocular and\/or facial adverse events in patients with atopic dermatitis: a multicenter retrospective study","volume":"13","author":"Beyrouti","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026012706470916400_ljaf424-B4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/derm.2022.0063","article-title":"Ocular adverse events in patients with atopic dermatitis treated with upadacitinib: a real-life experience","volume":"34","author":"Gelato","year":"2023","journal-title":"Dermatitis"},{"key":"2026012706470916400_ljaf424-B5","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/jdv.20233","article-title":"Evolution of dupilumab-associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO-ADOC study)","volume":"38","author":"Reguiai","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026012706470916400_ljaf424-B6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/ACI.0b013e3282efd0bf","article-title":"Clinical grading of atopic keratoconjunctivitis","volume":"7","author":"Calonge","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2026012706470916400_ljaf424-B7","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3390\/diagnostics14121272","article-title":"A case of refractory vernal keratoconjunctivitis showing improvement after the administration of upadacitinib for the treatment of atopic dermatitis","volume":"14","author":"Mima","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"2026012706470916400_ljaf424-B8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41586-024-08061-0","article-title":"Spatial proteomics identifies JAKi as treatment for a lethal skin disease","volume":"635","author":"Nordmann","year":"2024","journal-title":"Nature"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf424\/65007504\/ljaf424.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/2\/390\/65007504\/ljaf424.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/2\/390\/65007504\/ljaf424.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:47:14Z","timestamp":1769514434000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/194\/2\/390\/8305433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":8,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,28]]},"published-print":{"date-parts":[[2026,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf424","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,10,28]]}}}